Forcefield Therapeutics is a startup, 1 tracked investor.
Forcefield Therapeutics is a startup. Brouky records 1 investor associated with the company.
Forcefield Therapeutics develops biologic therapeutics aimed at protecting heart function by preventing or arresting the loss of cardiomyocytes that occurs following myocardial infarction, with the goal of reducing progression to heart failure.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.